|
US2012035120A1
|
|
Glycolipids as treatment for disease
|
|
WO2008073620A2
|
|
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
|
US2009311744A1
|
|
Expression of O-glycosylated therapeutic proteins in prokaryotic microorganisms
|
|
WO2007064904A2
|
|
Solvents for mutant endoglycoceramidases with synthetic activity
|
|
US2009203579A1
|
|
Glycopegylated granulocyte colony stimulating factor
|
|
WO2006066258A2
|
|
Lipoconjugation of peptides
|
|
US2008176790A1
|
|
Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
|
|
US2009292110A1
|
|
Enzymatic modification of glycopeptides
|
|
US2006111279A1
|
|
Glycopegylated erythropoietin
|
|
WO03045980A2
|
|
Glycopeptide remodeling using amidases
|
